Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
Danièl Thomas(Unknown), Ravindra Majeti(Stanford University)
Cited by 59
Related Papers
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
|Proceedings of the National Academy of Sciences|2012|256
Olsalazine Versus Sulfasalazine in Mild to Moderate Childhood Ulcerative Colitis
|Journal of Pediatric Gastroenterology and Nutrition|1993|66
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors
|Nature Biotechnology|2024|56